Topline The Oxford University team behind the Oxford-AstraZeneca Covid-19 shot has created the first vaccine against malaria that reaches the World Health Organization’s 75% efficacy threshold, according to preliminary results from a clinical trial published Thursday, a breakthrough in the fight against one of the world’s biggest killers. mosquito’s spread malaria getty Key Facts The vaccine, known as R21, is 77% effective against malaria, according to preliminary results from a Phase 2 clinical trial that have not been peer reviewed. The v… Click below to read the full story from Forbes
Read More